RESUMO
Pharmacotherapeutic intervention during traumatic memory consolidation has been suggested to alleviate or even prevent the development of posttraumatic stress disorder (PTSD). We recently reported that, in a controlled, prospective animal model, depriving rats of sleep following stress exposure prevents the development of a PTSD-like phenotype. Here, we report that administering the wake-promoting drug modafinil to rats in the aftermath of a stressogenic experience has a similar prophylactic effect, as it significantly reduces the prevalence of PTSD-like phenotype. Moreover, we show that the therapeutic value of modafinil appears to stem from its ability to stimulate a specific circuit within the hypothalamus, which ties together the neuropeptide Y, the orexin system and the HPA axis, to promote adaptive stress responses. The study not only confirms the value of sleep prevention and identifies the mechanism of action of a potential prophylactic treatment after traumatic exposure, but also contributes to understanding mechanisms underlying the shift towards adaptive behavioral response.
Assuntos
Adaptação Psicológica/efeitos dos fármacos , Compostos Benzidrílicos/farmacologia , Modelos Animais de Doenças , Hipotálamo/efeitos dos fármacos , Rede Nervosa/efeitos dos fármacos , Transtornos de Estresse Pós-Traumáticos/prevenção & controle , Transtornos de Estresse Pós-Traumáticos/psicologia , Vigília/efeitos dos fármacos , Animais , Nível de Alerta/efeitos dos fármacos , Nível de Alerta/fisiologia , Corticosterona/sangue , Humanos , Sistema Hipotálamo-Hipofisário/efeitos dos fármacos , Sistema Hipotálamo-Hipofisário/fisiopatologia , Masculino , Rememoração Mental/efeitos dos fármacos , Rememoração Mental/fisiologia , Modafinila , Neuropeptídeo Y/fisiologia , Orexinas/fisiologia , Sistema Hipófise-Suprarrenal/efeitos dos fármacos , Sistema Hipófise-Suprarrenal/fisiopatologia , Ratos , Ratos Sprague-DawleyAssuntos
Adjuvantes Farmacêuticos/administração & dosagem , Antidepressivos Tricíclicos/administração & dosagem , Fármacos Atuantes sobre Aminoácidos Excitatórios/administração & dosagem , Hipocampo/efeitos dos fármacos , Imipramina/administração & dosagem , Receptores de Glutamato Metabotrópico/efeitos dos fármacos , Aminoácidos/administração & dosagem , Animais , Compostos Bicíclicos Heterocíclicos com Pontes/administração & dosagem , Transtorno Depressivo/tratamento farmacológico , Modelos Animais de Doenças , Interações Medicamentosas , Quimioterapia Combinada , Hipocampo/citologia , Hipocampo/metabolismo , Técnicas In Vitro , Camundongos , Neurônios/efeitos dos fármacos , Ratos , Ratos Endogâmicos , Receptor Cross-Talk/efeitos dos fármacos , Receptores de Glutamato Metabotrópico/metabolismo , Fatores de Tempo , Xantenos/administração & dosagemRESUMO
Human and animal studies support the involvement of neuropeptide Y (NPY) in the pathophysiology of depression. Thus, hippocampal NPY-LI is decreased in genetic models of depression, the Flinders Sensitive Line and Fawn Hooded rats. Maternal "deprivation" has been identified as one risk factor in the development of psychopathology, including depression in adulthood. In view of these findings we hypothesized that brain NPY may also be decreased in an animal model of early life maternal deprivation. To test this hypothesis, male and female Sprague-Dawley rats were maternally separated (MS) 6 h/day or briefly handled from postnatal day 2 (PN2) to PN6 and from PN9 to PN13. At 12 weeks of age the rats were sacrificed, the brains dissected and NPY-LI measured by radioimmunoassay. MS rats had lower NPY-LI in the hippocampus. NPY-LI was also lower in female compared to male rats in hippocampus. Lastly, NPY-LI was increased in the hypothalamus of both male and female MS rats. These findings support the hypothesis that altered NPY in the limbic region is a common denominator of several models of depression and might be a trait marker of vulnerability to affective disorders.
Assuntos
Depressão/metabolismo , Hipocampo/metabolismo , Hipotálamo/metabolismo , Privação Materna , Neuropeptídeo Y/metabolismo , Animais , Animais Recém-Nascidos , Depressão/fisiopatologia , Modelos Animais de Doenças , Feminino , Lobo Frontal/crescimento & desenvolvimento , Lobo Frontal/metabolismo , Hipocampo/crescimento & desenvolvimento , Hipotálamo/crescimento & desenvolvimento , Masculino , Gravidez , Radioimunoensaio , Ratos , Ratos Sprague-Dawley , Fatores SexuaisRESUMO
mRNA recovery from brain tissue is affected by time-interval from death to inactivation of tissue, and may depend on sacrificial method. Sacrifice by high-energy microwave irradiation increases recovery of intact neuropeptides and proteins, and it has been suggested that this may be valid also for neuropeptide mRNAs. We therefore compared post-mortem NPY mRNA recovery following decapitation or microwave irradiation. Total RNA yield was significantly higher in tissue from decapitated rats. A decline in NPY mRNA (amol/mg tissue) over time, presumably reflecting degradation, was found in frontal cortex, hippocampus and striatum. Following high-energy microwaves, NPY message levels were higher in occipital cortex, lower in the hypothalamus, and unaltered in the other brain regions examined. These results show that post-mortem processes contribute to estimates of NPY mRNA levels obtained using standard methods for obtaining brain tissue from experimental animals and raise the question whether different pools of NPY mRNA might be differentially affected by post-mortem degradation. A general protective effect of high-energy radiation against degradation is not supported.
Assuntos
Química Encefálica , Neuropeptídeo Y/análise , Mudanças Depois da Morte , Animais , Encéfalo/efeitos da radiação , Corpo Estriado/química , Lobo Frontal/química , Hipocampo/química , Hipotálamo/química , Masculino , Micro-Ondas , Neuropeptídeo Y/genética , Lobo Occipital/química , Estabilidade de RNA/efeitos da radiação , RNA Mensageiro/análise , Ratos , Ratos Sprague-DawleyRESUMO
OBJECTIVE: Central tachykinin levels (i.e., substance P [SP], neurokinin A [NKA], neurokinin B [NKB] and neurokinin K [NKK]) have been reported to fluctuate in association with stress and anxiety. Ethanol can also modulate stress and anxiety. Further, ethanol intake can change as a result of stress and anxiety. This suggests possible interactions between ethanol and central tachykinins, i.e., changing tachykinin levels could influence ethanol intake and vice versa. However, to date few studies have assessed the potential relationship between tachykinin levels in the brain and ethanol preference. The present study was designed to determine if rodent lines selectively bred for differences in alcohol preference (i.e., alcohol-preferring [P] and non-preferring [NP] rats) have different tachykinin levels in the brain. METHOD: Tissue samples from the brains of ethanol-naive P and NP rats were collected from the frontal cortex, caudate, hippocampus, amygdala and hypothalamus. Using radioimmuno assays, concentrations of SP-like immunoreactivity (SP-LI) and neurokinin-like immunoreactivity (NK-LI, i.e., neurokinin A, B and K) in P and NP rats were determined. RESULTS: In P rats, SP-LI was significantly lower in the frontal cortex (F= 12.80, 1/26 df, p = .001) while NK-LI was significantly lower in the frontal cortex (F = 7.36, 1/26 df, p = .012) and hypothalamus (F = 5.32, 1/26 df, p = .029) compared with NP rats. CONCLUSIONS: These data indicate that endogenous SP and neurokinin levels are reduced in discrete brain regions of P rats compared with NP rats. These decreases may be associated with decreased serotonergic innervation of these brain regions in P rats compared with NP rats.
Assuntos
Consumo de Bebidas Alcoólicas/metabolismo , Córtex Cerebral/metabolismo , Hipotálamo/metabolismo , Neurocinina A/metabolismo , Neurocinina B/metabolismo , Substância P/metabolismo , Consumo de Bebidas Alcoólicas/genética , Animais , Masculino , Ratos , Especificidade da EspécieRESUMO
Antidepressant drugs as well as electroconvulsive stimuli can significantly influence brain concentrations of neurotrophic factors. However, it is not known whether the baseline brain concentrations of neurotrophic factors are altered in human subjects suffering from affective disorders or whether there are sex differences in concentrations of neurotrophins in human brain. In order to elucidate some of these questions, we measured by ELISA brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) in an animal model of depression, the Flinders Sensitive Line (FSL) rats and their controls, the Flinders Resistant Line (FRL). Altered BDNF and NGF concentrations were found in frontal cortex, occipital cortex, and hypothalamus of depressed FSL compared to FRL control rats. Furthermore, different levels of these neurotrophins were also found in the male and female brain. Cumulatively these observations suggest that BDNF and NGF may play a role in depression and, hypothetically, different brain regional concentrations of BDNF and NGF in male and female animals may be relevant to gender differences in vulnerability to depression.
Assuntos
Fator Neurotrófico Derivado do Encéfalo/análise , Encéfalo/metabolismo , Depressão/metabolismo , Fator de Crescimento Neural/análise , Animais , Encéfalo/patologia , Química Encefálica/genética , Corpo Estriado/química , Corpo Estriado/metabolismo , Modelos Animais de Doenças , Ensaio de Imunoadsorção Enzimática , Feminino , Lobo Frontal/química , Lobo Frontal/metabolismo , Hipotálamo/química , Hipotálamo/metabolismo , Técnicas In Vitro , Masculino , Lobo Occipital/química , Lobo Occipital/metabolismo , Tamanho do Órgão , Ratos , Ratos Endogâmicos , Fatores SexuaisRESUMO
Neuropeptide Y (NPY) is a hexatriacontapeptide amide that is now well characterized as a neuromodulator in the central nervous system (CNS). When infused into the CNS, NPY produces both anxiolytic and orexigenic effects. NPY's anxiolytic effects appear to be mediated through receptors in the central amygdala, whereas its orexigenic effects are localized in discrete hypothalamic nuclei. Both food restriction and food deprivation produce increased levels of the peptide in the hypothalamus that are ameliorated by refeeding. However, the effects of alcohol consumption/deprivation on NPY levels remain unknown. The present study sought to determine if brain NPY levels were affected by either alcohol exposure and/or correlated with genetic differences in preference for drinking alcohol. In the first experiment, NPY-like immunoreactivity (NPY-LI) was compared in alcohol-naive, alcohol-preferring (P), and nonpreferring (NP) rats. After tissue extraction, NPY-LI was measured by radioimmunoassay: amygdala, hippocampus, frontal cortex, hypothalamus, and caudate. P rats were found to have significantly lower NPY-LI in amygdala (F = 4.69, p < 0.04), hippocampus (F = 7.03, p < 0.01), and frontal cortex (F = 4.7, p < 0.04), compared with NP rats. In the second experiment, heterozygous Wistar rats were exposed to alcohol for 14 hr/day for 7 weeks in alcohol vapor chambers (mean blood alcohol concentrations = 180 mg%) or control chambers. At 7 weeks of alcohol exposure, no significant changes in NPY-LI in were found. At 1 month after ethanol withdrawal, however, the ethanol-exposed animals had significantly higher NPY-LI in the hypothalamus (F = 4.78, p < 0.04) when compared with the nonexposed controls. Taken together, these studies suggest that exposure to chronic ethanol may affect NPY-LI at the level of the hypothalamus in a fashion similar to food restriction, because 4 weeks after alcohol withdrawal, significantly higher NPY levels are found. In addition, differences in NPY-LI in limbic areas and frontal cortex between alcohol-naive P and NP rats suggest that NPY may also play a role in risk for the development of alcohol preference either by modulating the "tension-reduction" properties of alcohol or by influencing consummatory behaviors.
Assuntos
Consumo de Bebidas Alcoólicas/genética , Motivação , Neuropeptídeo Y/fisiologia , Administração por Inalação , Consumo de Bebidas Alcoólicas/fisiopatologia , Alcoolismo/genética , Alcoolismo/fisiopatologia , Tonsila do Cerebelo/fisiopatologia , Animais , Nível de Alerta/fisiologia , Encéfalo/fisiopatologia , Mapeamento Encefálico , Etanol/farmacocinética , Hipotálamo/fisiopatologia , Masculino , Ratos , Ratos WistarRESUMO
1. Eighty rats were randomized into four groups receiving one of the following diets: rat chow containing (1) 6% soybean oil, (2) 6% primrose oil, (3) 6% fish oil, (4) a combination of 4.5% primrose and 1.5% fish oil. 2. Following two months of each regimen, the rats were sacrificed by microwave irradiation and the brain's fatty acid composition was analysed with gas chromatography for each of the following regions: frontal cortex, striatum, occipital cortex, hippocampus, hypothalamus, cerebellum and pituitary. 3. Linoleic acid was decreased by both primrose and fish oil supplementations. The fish oil substitution resulted in a significant elevation of 20:3n-6, a decrease of 22:4n-6 and a non-significant decrease of 20:4n-6, probably reflecting inhibition of delta-5-desaturation. At the same time the fish oil diet significantly elevated 22:5n-3 while 22:5n-6 was decreased. 4. The primrose oil diet lowered the n-3/n-6 ratio in all regions except in the cerebellum. In contrast, the fish oil diet elevated the n-3/n-6 ratio in all regions. 5. The results demonstrate that changes in dietary fat composition can alter the fatty acid composition of the adult rat brain and that these effects are region specific. 6. This is of interest since metabolites of essential fatty acids may be involved in physiological and pathological processes in the brain and it has been hypothesized that dietary intake of fats may influence the outcome of psychiatric disorders such as schizophrenia.
Assuntos
Encéfalo/metabolismo , Gorduras na Dieta , Ácidos Graxos/metabolismo , Animais , Modelos Animais de Doenças , Ácidos Graxos/análise , Masculino , Distribuição Aleatória , Ratos , Ratos Sprague-Dawley , Esquizofrenia/etiologiaRESUMO
Rats were pretreated with 0.9% NaCl, or 0.1 or 1.0 mg/kg MK-801, an anticonvulsant and a psychotomimetic drug, and 60 minutes later given ECS or sham ECS. After six sessions the animals were sacrificed and neuropeptide Y (NPY-), neurokinin A (NKA-), and calcitonin gene-related peptide (CGRP-) like immunoreactivity (-LI) measured with radioimmunoassays. ECS increased NPY-LI in frontal cortex, striatum, occipital cortex and hippocampus, and NKA-LI in occipital cortex and hippocampus. MK-801 increased CGRP in a dose-response manner in frontal cortex, and NKA-LI in occipital cortex. Although the higher MK-801 dose reduced seizure duration by 50%, the ECS induced NPY-LI increase in striatum, occipital cortex and hippocampus, and NKA-LI in occipital cortex was not diminished. In contrast, there was a parallel decrease in seizures and NPY-LI and NKA-LI changes in frontal cortex and hippocampus, respectively. Investigation of neuropeptides in brain may contribute to understanding of the mechanisms of action of antidepressive and antipsychotic treatments and of psychotomimetic drugs.